Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Morgan Stanley

Calvert Small-Cap Fund Class A (CCVAX)

Ticker CCVAX · · Holdings as of Jun 30, 2026

Expense ratio
1.2%$120/yr per $10k
5-yr return
+2.1%annualized
1-yr return
−11.3%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
69

Bottom line

Is CCVAX a good fund? The bottom line

CCVAX is the Class A share class of Calvert Small-Cap Fund, a managed small-cap mutual fund from Morgan Stanley.

Its expense ratio is 1.2% — about $120 a year on every $10,000 invested, more expensive than 70% of small-cap funds we track.

It returned −11.3% over one year, +2.1% a year over five years, +7.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.3 billion in net assets and 69 holdings, its largest position is Dorman Products Inc (3.5%) and the top 10 make up 30% of the portfolio.

This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 5.25%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What CCVAX invests in

The Funds investment objective is to seek to provide long-term capital appreciation through investment primarily in small-cap common stocks of U.S. companies.

The Fund normally invests at least 80% of its net assets, including borrowings for investment purposes, in common stocks of small companies (the 80% Policy). The Fund defines small companies as those whose market capitalization falls within the range of the Russell 2000 Index at the time of investment. As of December 31, 2025, the market capitalization of the Russell 2000 Index companies ranged from $1 million to $31.3 billion with a weighted average market capitalization of $4.5 billion. Market capitalizations of companies within the Russell 2000 Index are subject to change. The Fund may also invest up to 25% of its net assets in foreign securities (including American Depositary Receipts (ADRs), which are either sponsored or unsponsored, and Global Depositary Receipts (GDRs)). The Fund may also invest in publicly-traded real estate investment trusts (REITs) and may also lend its…

From the fund's prospectus (filed Jan 27, 2026).

CCVAX performance

Fund calendar-year total returns, 2016–2025 2016: +20.0%; 2017: +13.2%; 2018: −6.9%; 2019: +26.0%; 2020: +14.6%; 2021: +19.7%; 2022: −16.1%; 2023: +11.4%; 2024: +11.9%; 2025: −6.4% +20% 2016 +13% 2017 −7% 2018 +26% 2019 +15% 2020 +20% 2021 −16% 2022 +11% 2023 +12% 2024 −6% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
CCVAX−11.3%+2.1%+7.3%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full CCVAX performance history →

What CCVAX costs

On a $10,000 investment, CCVAX's 1.2% expense ratio costs about $120 a year. The prospectus estimates $1,903 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full CCVAX fee table →

CCVAX top 10 holdings

#Holding% of fund
1Dorman Products Inc3.47%
2Franklin Electric Co Inc3.47%
3CSW Industrials Inc3.41%
4Valvoline Inc3.17%
5Community Financial System Inc3.14%
6Donaldson Co Inc2.99%
7Essential Properties Realty Trust Inc2.77%
8Old National Bancorp/IN2.55%
9Quaker Chemical Corp2.53%
10IDACORP Inc2.47%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 30% of the fund. See all top 25 holdings and asset mix →

Alternatives to CCVAX

More funds like CCVAX →

CCVAX FAQ

What is the expense ratio of CCVAX?
CCVAX's expense ratio is 1.2%, which works out to about $120 a year for every $10,000 invested. The prospectus estimates total costs of $1,903 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CCVAX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; front-end sales load up to 5.25%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does CCVAX hold?
CCVAX's largest holdings are Dorman Products Inc (3.5%), Franklin Electric Co Inc (3.5%), CSW Industrials Inc (3.4%), Valvoline Inc (3.2%), Community Financial System Inc (3.1%). It holds 69 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is CCVAX's 5-year return?
CCVAX returned +2.1% a year over the five years ending Dec 31, 2025, and +7.3% a year over ten years. Past performance does not guarantee future results.
Does CCVAX have a sales load?
Yes. CCVAX has a maximum front-end sales charge of 5.25%.
Who manages CCVAX?
CCVAX is offered by Morgan Stanley through Calvert Impact Fund, Inc..